Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2007
12/27/2007US20070299108 New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents
12/27/2007US20070299107 N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
12/27/2007US20070299106 Novel mycobacterial inhibitors
12/27/2007US20070299105 2-Cyanopropanoic Acid Amide and Ester Derivatives and Methods of Their Use
12/27/2007US20070299104 Tetrahydropyranyl Cyclopentyl 1-Substituted and 1,1-Disubstituted Tetrahydroisoquinoline Modulators of Chemokine Receptor Activity
12/27/2007US20070299103 [1,2,4]Triazolo[4,3-A]Pyridine Derivatives for the Treatment of Hyperproliferative Diseases
12/27/2007US20070299102 Diphenyl Ox-Indol-2-One Compounds and Their Use in the Treatment of Cancer
12/27/2007US20070299101 Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment
12/27/2007US20070299100 Analgesic
12/27/2007US20070299099 Acid Addition Salt of Irinotecan
12/27/2007US20070299098 Therapeutic Agent for Neuropathic Pain
12/27/2007US20070299097 Strategy for Leukemia Therapy
12/27/2007US20070299096 Treating Learning Deficits With Inhibitors of Hmg CoA Reductase
12/27/2007US20070299095 Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
12/27/2007US20070299094 4-(3-benzoylaminophenyl)-6,7-dimethoxy-2-methylaminoquinazoline derivatives
12/27/2007US20070299093 Organic Compounds Useful for the Treatment of Alzheimer's Disease, Their Use and Method of Preparation
12/27/2007US20070299092 Quinone Substituted Quinazoline and Quinoline Kinase Inhibitors
12/27/2007US20070299091 Azaindole Carboxamides
12/27/2007US20070299090 Substituted 8-aminoalkoxy-xanthine compounds and compositions useful in the treatment of hyperlipidemia and diabetes
12/27/2007US20070299089 Use of A2A Adenosine Receptor Agonists in the Treatment of Ischemia
12/27/2007US20070299088 Novel Uses of 2-Phenyl-Substituted Imidazotriazinone Derivatives
12/27/2007US20070299087 New Compounds 319
12/27/2007US20070299086 such as {[5-(3-Chloro-phenyl)-3-hydroxy-pyridine-2-carbonyl]-amino}-acetic acid methyl ester; for controlling Peripheral Vascular Disease, Coronary Artery Disease, heart failure, ischemia, and anemia
12/27/2007US20070299084 Indole Derivatives Useful for Treating Resistance to Antitumor Agents
12/27/2007US20070299083 6-Methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline hydrochloric acid salts
12/27/2007US20070299082 (+-)-3-(6-Phenylethynyl-pyridazin-3-yloxy)-1-aza-bicyclo[2.2.2]octane; (+-)-N-{4-[6-(1-Aza-bicyclo[2.2.2]oct-3-yloxy)-pyridazin-3-ylethynyl]-phenyl}-acetamide; nicotinic and monoamine receptor modulators
12/27/2007US20070299081 Heterocyclic Derivatives and Their Use as Mediators of Stearoyl-Coa Desaturase
12/27/2007US20070299080 Benzamide derivatives and uses related thereto
12/27/2007US20070299079 4-AMINO-PYRIDO[3,2-e]PYRAZINES, THEIR USE AS INHIBITORS OF PHOSPHODIESTERASE 10, AND PROCESSES FOR PREPARING THEM
12/27/2007US20070299078 Quinoxalinyl Macrocyclic Hepatitis C Virus Serine Protease Inhibitors
12/27/2007US20070299077 Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament
12/27/2007US20070299076 Substituted 3-Amino-Pyrrolidino-4-Lactams
12/27/2007US20070299075 e.g. 1-[4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methyl-pyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-4-(aminosulfonyl)aminobutan-2-ol; inhibit the tyrosine kinase activity of endothelial and fibroblast growth factors receptors; angiogenesis inhibitor; anticarcinogenic agent
12/27/2007US20070299074 Guanidine Compounds, and Use Thereof as Binding partners for 5-Ht5 Receptors
12/27/2007US20070299073 Imidazolyl derivatives
12/27/2007US20070299072 Kv1.5 potassium channel inhibitors
12/27/2007US20070299071 Substituted phenyl methanone derivatives
12/27/2007US20070299070 Such as 5-(benzyloxy)-N-[4-(morpholinomethyl)phenyl]-1H-indole-2-carboxamide and 5-(benzyloxy)-N-[4-(morpholinomethyl)phenyl]-1H-benzimidazole-2-carboxamide; melanin-concentrating hormone receptor antagonist, useful for treating obesity
12/27/2007US20070299069 Methods for treating hepatitis C
12/27/2007US20070299068 viricides comprising (3-cyano-indol-2-yl)phenyl derivatives, used for for treating viral diseases and infections or for affecting viral internal ribosome entry site (IRES) activity
12/27/2007US20070299067 Quinoline and isoquinoline derivatives as phosphodiesterase 10 inhibitors
12/27/2007US20070299066 Novel Pyrimidothienoindazoles
12/27/2007US20070299065 Tetrahydropyran Derivatives as Antidiabetics
12/27/2007US20070299063 N3 alkylated benzimidazole derivatives as mek inhibitors
12/27/2007US20070299062 Obesity; no stimulation of the central nervous system and no peripheral activity caused by activation of 5-HT2c receptors; improved cellular potency and pharmacokinetics; 6-(4-Chlorophenyl)-3-(6-((4-morpholinopiperidin-1-yl)methyl)-1,2,3,4-tetrhaydronapthalene-2-yl)thieno[3,2,-d]pyrimidin-4-(3H)-one
12/27/2007US20070299061 such as 4-Pyridin-3-yl-2,5-dihydro-pyridazino[4,5-b]indol-1-one, used as inhibitors of vascular endothelial growth factor receptor (VEGFR) kinase, mixed lineage kinase (MLK) or cyclin-dependent kinase (CDK); treatment of angiogenic disorders and neurodegenerative diseases
12/27/2007US20070299060 (1R,2R,3S,4S)-5-fluoro-N4-[3- methylaminocarbonylbicyclo[2.2.1]hept-5- en-2-yl)-N2-[1-methylsulfonyl-2,3- dihydroindol-5-yl]-2,4-pyrimidinediamine, used to inhibit cellular proliferation and to treat proliferate diseases such as tumorigenic cancers
12/27/2007US20070299059 Compostions and methods relating to novel compounds and targets thereof
12/27/2007US20070299058 Anxiolytic Agents With Reduced Sedative And Ataxic Effects
12/27/2007US20070299057 Heterocyclic piperidines as modulators of chemokine receptor activity
12/27/2007US20070299056 Benzazepine derivatives for the treatment of neurological disorders
12/27/2007US20070299055 Combination of sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
12/27/2007US20070299054 Oral pharmaceutical composition of a poorly water-soluble active agent
12/27/2007US20070299053 N-(2-hydroxy-3-methyl-butyryl)-1-(L-alaninyl)-1-amino-3-methyl-4,5,6,7-tetrahydro-2H-3-benzazepin-2-one; inhibiting beta amyloid peptide release and/or synthesis
12/27/2007US20070299052 Inhibitors of IAP
12/27/2007US20070299051 Tricyclic Guanidine Derivatives as Sodium-Proton Exchange Inhibitors
12/27/2007US20070299050 TNF alpha inhibitors; inflammatory diseases such as rheumatoid arthritis, Crohn's disease, septic shock syndrome and atherosclerosis
12/27/2007US20070299049 Pharmaceutical Uses of Staurosporine Derivatives
12/27/2007US20070299048 Combination of Gaboxadol and 5Ht2 Antagonists
12/27/2007US20070299047 Combination of Organic Compounds
12/27/2007US20070299046 Orally available light-independent antineoplastic compounds
12/27/2007US20070299045 Anti-Viral Composition for the Topical Treatment of Herpes Labialis (Cold Sores) and Method for Use Thereof
12/27/2007US20070299044 Corticosteroid Topical Dispersion with Low Content of Surfactant
12/27/2007US20070299043 Anti-scarring drug combinations and use thereof
12/27/2007US20070299042 Use of etodolac to treat hyperplasia
12/27/2007US20070299041 Induction of innate immunity by vitamin d3 and its analogs
12/27/2007US20070299040 Composition for Preventing a Cold
12/27/2007US20070299039 Substituted benz-azoles and methods of their use as inhibitors of Raf kinase
12/27/2007US20070299036 Antidiabetic agents
12/27/2007US20070299035 Use of chemical chelators as reversal agents for drug-induced neuromuscular block
12/27/2007US20070299034 Cell wall derivatives, their preparation process, and use thereof
12/27/2007US20070299033 stavudine:melamine co-crystal or stavudine:2-aminopyridine co-crystal; therapeutics; shelf-life, bioavailability
12/27/2007US20070299032 Method and Composition for Thickening Hair
12/27/2007US20070299031 Therapeutic agent for tumor of neural origin
12/27/2007US20070299029 Hepatic stellate cell specific promoter and uses thereof
12/27/2007US20070299028 Backbone modifications to modulate oligonucleotide targeting in vivo
12/27/2007US20070299027 Compositions and their uses directed to huntingtin
12/27/2007US20070299026 Immunosuppressive Cytokine
12/27/2007US20070299025 Method for Detecting the Risk of Cardiovascular Diseases Such as Acute Myocardial Infarction and Coronary Heart Disease By Analysing Defesin
12/27/2007US20070299024 Cloning And Characterization Of 5'Flanking Regions Of A Human Aggrecanase-1 Gene
12/27/2007US20070299022 Antisense Oligonucleotide to Inhibit Melanoma Inhibitory Activity Mia
12/27/2007US20070299021 Modified Tailed Oligonucleotides
12/27/2007US20070299020 Methods for treatment of ovarian, colorectal or pancreatic cancer using 4-(aminno)-2(2,6-dioxo(3-piperidyl)-isoindoline-1,3-dione
12/27/2007US20070299019 Macrolides and methods for producing same
12/27/2007US20070299018 Derivatives of Genkwanin and Sakuranetin, Cosmetic and Therapeutic Use Thereof and Preparation Method of Same
12/27/2007US20070299017 Compositions for lowering blood serum cholesterol and use in foods, beverages, and health supplements
12/27/2007US20070299012 Method of preventing progression of hypertension-induced heart failure with PKC peptides
12/27/2007US20070299006 Secreted by yeast; storage stability; nonimmunogenic; vaccine; long half-life; use for growth hormone deficiency in human or animal to stimulate meat production
12/27/2007US20070298999 Method for treating pain with a calmodulin inhibitor
12/27/2007US20070298470 Improving manufacture of clavulanic acid; DNA encoding genes essential for clavam-2-carboxylate (C2C), 2-hydroxymethylclavam (2HMC), or 2-(3-alanyl)clavam (AC) biosynthesis in S. clavuligerus which are not essential for clavulanic acid biosynthesis
12/27/2007US20070298426 Warfarin dosage prediction
12/27/2007US20070298420 Cholesterol transport gene
12/27/2007US20070298133 Compositions and kits comprising a melatonin component and a flavanol component
12/27/2007US20070298132 Berberine as a selective lung cancer agent
12/27/2007US20070298129 Compounds and compositions for treating neuronal death or neurological dysfunction
12/27/2007US20070298126 Method for the eradication of pathogens including S. aureus and antibiotic resistant microbes from the upper respiratory tract of mammals and for inhibiting the activation of immune cells
12/27/2007US20070298123 Anti-angiogenic compositions and methods of use
12/27/2007US20070298122 Copper lowering treatment of inflammatory and fibrotic diseases
12/27/2007US20070298121 Using compositions containing zinc ions, calcium ions, rubidium ions and/or potassium ions; modulates matrix metalloproteinases (MMPs),
12/27/2007US20070298117 Compositions and kits comprising a melatonin component and a chondroprotective component
1 ... 3442 3443 3444 3445 3446 3447 3448 3449 3450 3451 3452 3453 3454 3455 3456 3457 3458 3459 3460 3461 3462 ... 7860